Alzamend Neuro, Inc. (ALZN) AI Dilution Summary

Cash was $7,591,444 at 2026-07-31 against estimated monthly burn of $379,506. The most recent capital raised was a $7,500,000 gross private placement of preferred stock that closed 2026-07-31; that amount is already included in the cash figure. The main source of dilution is the $25,000,000 Series D preferred commitment from Ault Lending, LLC: $7,500,000 has been drawn and $17,500,000 remains.